There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.
Biogen Inc. has divulged 3-β-hydroxysteroid-δ(8),δ(7)-isomerase (EBP) inhibitors reported to be useful for the treatment of autoimmune disease and multiple sclerosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback